5 Questions on Preventing, Diagnosing Melanoma

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Explore the latest advancements in pancreatic cancer treatment, focusing on genetic mutations, targeted therapies, and emerging clinical strategies.

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Benjamin J. Golas, MD

June 30th 2025

SonoClear System Earns Breakthrough Designation for Intracranial Procedures

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

The system showed enhanced diagnostic accuracy of intraoperative imaging, potentially improving the extent of resection while reducing residual disease.

Roman Fabbricatore

Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting

The system showed enhanced diagnostic accuracy of intraoperative imaging, potentially improving the extent of resection while reducing residual disease.

Stephen Liu, MD, and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.

Stephen V. Liu, MD;Joshua K. Sabari, MD

June 23rd 2025

MARIPOSA OS Results Are Significant for EGFR+ NSCLC

Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.

The MARIPOSA trial revealed promising survival benefits with amivantamab plus lazertinib vs osimertinib for patients with EGFR-mutant lung cancer.

17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses

The MARIPOSA trial revealed promising survival benefits with amivantamab plus lazertinib vs osimertinib for patients with EGFR-mutant lung cancer.

Daniella Natanov;Sharon Koehler

July 1st 2025

3 Things You Should Know About Targeting NRG1 and Rare Drivers in Pancreatic Cancer

Related Content

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Explore the latest advancements in pancreatic cancer treatment, focusing on genetic mutations, targeted therapies, and emerging clinical strategies.

Benjamin J. Golas, MD

June 30th 2025

SonoClear System Earns Breakthrough Designation for Intracranial Procedures

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Roman Fabbricatore

Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting

The system showed enhanced diagnostic accuracy of intraoperative imaging, potentially improving the extent of resection while reducing residual disease.

Stephen V. Liu, MD;Joshua K. Sabari, MD

June 23rd 2025

MARIPOSA OS Results Are Significant for EGFR+ NSCLC

Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.